Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons.

Tran NN, Ladran IG, Brennand KJ.

Schizophr Bull. 2013 Jan;39(1):4-10. doi: 10.1093/schbul/sbs127. Epub 2012 Nov 19.

2.

Modeling psychiatric disorders at the cellular and network levels.

Brennand KJ, Simone A, Tran N, Gage FH.

Mol Psychiatry. 2012 Dec;17(12):1239-53. doi: 10.1038/mp.2012.20. Epub 2012 Apr 3. Review.

3.

Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.

Brennand KJ, Landek-Salgado MA, Sawa A.

Biol Psychiatry. 2014 Jun 15;75(12):936-44. doi: 10.1016/j.biopsych.2013.10.025. Epub 2013 Nov 15. Review.

4.

Modeling psychiatric disorders through reprogramming.

Brennand KJ, Gage FH.

Dis Model Mech. 2012 Jan;5(1):26-32. doi: 10.1242/dmm.008268. Epub 2011 Oct 4. Review.

5.

Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells.

Onorati M, Camnasio S, Binetti M, Jung CB, Moretti A, Cattaneo E.

Mol Cell Neurosci. 2010 Mar;43(3):287-95. doi: 10.1016/j.mcn.2009.12.002. Epub 2009 Dec 21.

PMID:
20026276
6.

A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia.

Jacobs BM.

Schizophr Res. 2015 Oct;168(1-2):563-8. doi: 10.1016/j.schres.2015.07.005. Epub 2015 Jul 17. Review.

PMID:
26194993
7.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
8.

Pluripotent stem cells as a model to study oxygen metabolism in neurogenesis and neurodevelopmental disorders.

Paulsen Bda S, da Silveira MS, Galina A, Rehen SK.

Arch Biochem Biophys. 2013 Jun;534(1-2):3-10. doi: 10.1016/j.abb.2012.10.009. Epub 2012 Oct 27. Review.

PMID:
23111185
9.

Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.

Qiang L, Fujita R, Abeliovich A.

Neuron. 2013 Jun 19;78(6):957-69. doi: 10.1016/j.neuron.2013.06.002. Review.

10.

Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.

Brennand KJ, Gage FH.

Stem Cells. 2011 Dec;29(12):1915-22. doi: 10.1002/stem.762. Review.

11.

Enhancing induced pluripotent stem cell models of schizophrenia.

Wright R, Réthelyi JM, Gage FH.

JAMA Psychiatry. 2014 Mar;71(3):334-5. doi: 10.1001/jamapsychiatry.2013.4239. Review. No abstract available.

PMID:
24382673
12.

Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells.

Lemonnier T, Blanchard S, Toli D, Roy E, Bigou S, Froissart R, Rouvet I, Vitry S, Heard JM, Bohl D.

Hum Mol Genet. 2011 Sep 15;20(18):3653-66. doi: 10.1093/hmg/ddr285. Epub 2011 Jun 17.

PMID:
21685203
13.

Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.

Lu HE, Yang YC, Chen SM, Su HL, Huang PC, Tsai MS, Wang TH, Tseng CP, Hwang SM.

Exp Cell Res. 2013 Feb 15;319(4):498-505. doi: 10.1016/j.yexcr.2012.09.017. Epub 2012 Oct 4.

PMID:
23041301
14.

Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells.

Hewitt KJ, Shamis Y, Hayman RB, Margvelashvili M, Dong S, Carlson MW, Garlick JA.

PLoS One. 2011 Feb 28;6(2):e17128. doi: 10.1371/journal.pone.0017128.

15.

Neuronal differentiation potential of mouse induced pluripotent stem cells.

Yao XL, Liu Q, Ye CH, Li ZP, Lu XL, Li PL, Li XB, Li WQ.

Neuroreport. 2011 Oct 5;22(14):689-95. doi: 10.1097/WNR.0b013e32834a280a.

PMID:
21849916
16.

Disease-specific, neurosphere-derived cells as models for brain disorders.

Matigian N, Abrahamsen G, Sutharsan R, Cook AL, Vitale AM, Nouwens A, Bellette B, An J, Anderson M, Beckhouse AG, Bennebroek M, Cecil R, Chalk AM, Cochrane J, Fan Y, Féron F, McCurdy R, McGrath JJ, Murrell W, Perry C, Raju J, Ravishankar S, Silburn PA, Sutherland GT, Mahler S, Mellick GD, Wood SA, Sue CM, Wells CA, Mackay-Sim A.

Dis Model Mech. 2010 Nov-Dec;3(11-12):785-98. doi: 10.1242/dmm.005447. Epub 2010 Aug 10.

17.

Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.

Jang J, Yoo JE, Lee JA, Lee DR, Kim JY, Huh YJ, Kim DS, Park CY, Hwang DY, Kim HS, Kang HC, Kim DW.

Exp Mol Med. 2012 Mar 31;44(3):202-13. doi: 10.3858/emm.2012.44.3.015.

18.

Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N.

Hum Mol Genet. 2011 Dec 1;20(23):4530-9. doi: 10.1093/hmg/ddr394. Epub 2011 Sep 7.

PMID:
21900357
19.

Viable fertile mice generated from fully pluripotent iPS cells derived from adult somatic cells.

Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Wang X, Wang L, Zeng F, Zhou Q.

Stem Cell Rev. 2010 Sep;6(3):390-7. doi: 10.1007/s12015-010-9160-3. Review.

PMID:
20549390
20.

Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells.

Ogawa S, Tokumoto Y, Miyake J, Nagamune T.

In Vitro Cell Dev Biol Anim. 2011 Aug;47(7):464-9. doi: 10.1007/s11626-011-9435-2. Epub 2011 Jun 22.

PMID:
21695581

Supplemental Content

Support Center